Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for activating p21 gene expression

一种p21、基因的技术,应用在分子生物学领域,能够解决改变宿主基因组免疫反应等问题

Pending Publication Date: 2021-11-02
SINO US INST OF RNA TECH
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Traditional virus-based gene therapy systems have inherent drawbacks, including the potential to alter the host genome and cause side effects such as immune responses

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for activating p21 gene expression
  • Method for activating p21 gene expression
  • Method for activating p21 gene expression

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0056] As used herein, the term "synthesis" refers to the way of synthesizing oligonucleotides, including any way capable of synthesizing RNA, such as chemical synthesis, in vitro transcription, vector expression, and the like. The preparation method of the small activating nucleic acid molecule provided by the invention includes sequence design and sequence synthesis. The synthesis of the small activating nucleic acid molecular sequence can be done by chemical synthesis, or entrusted to a biotechnology company specialized in nucleic acid synthesis. Generally speaking, the chemical synthesis method includes the following four processes: (1) synthesis of oligoribonucleotides; (2) deprotection; (3) purification and separation; (4) desalting and annealing. For example, the specific steps of chemical synthesis of double-stranded RNA molecules such as saRNA in the present invention are as follows:

[0057] (1) Synthesis of oligoribonucleotides

[0058] Set to synthesize 1 micromo...

Embodiment 1

[0080] Example 1: Screening for functional small activating RNA (saRNA) targeting the p21 gene promoter region

[0081] In order to screen functional small activating RNAs that can activate the expression of the p21 gene, the 1 kb promoter sequence of the p21 gene was retrieved from the UCSC Genome database ( figure 1). A target site with a size of 19 bp was selected from -1 kb upstream of the transcription start site (TSS), and moved to the TSS site by moving 1 bp at a time to obtain a total of 982 target site sequences. The target sequence was filtered to exclude target sequences with GC content higher than 65% or lower than 35% and containing 5 or more consecutive identical nucleotides. After filtering, the remaining 439 target sequences entered the screening process as candidates. Based on these candidate sequences, corresponding double-stranded double-stranded RNA molecules are chemically synthesized. Wherein, the length of the sense and antisense strands of the double...

Embodiment 2

[0110] Example 2: saRNA induces p21 gene mRNA expression and inhibits cancer cell proliferation

[0111]To further evaluate the role of p21 saRNA in inducing p21 gene mRNA expression and inhibiting cancer cell proliferation, the saRNAs (RAG1-431, RAG1-553, RAG1-688) screened by QuantiGene 2.0 were transfected into the cancer cell line KU-7 (bladder cancer) , HCT116 (colon cancer) and HepG2 (hepatocellular carcinoma). The results showed that in all the above cell lines, saRNA could induce at least double the expression level of p21 gene mRNA and inhibit cell proliferation, revealing the efficacy of saRNA-mediated p21 induction. Specifically, RAG1-431, RAG1-553, and RAG1-688 were transfected into KU7 cells, respectively, which induced the expression of p21 mRNA by 14.0, 36.9, and 31.9 times, and produced survival rates of 71.7%, 60.7%, and 67.4% ( Figure 5 ). RAG1-431, RAG1-553, and RAG1-688 were transfected into HCT116 cells, respectively, to induce p21 mRNA expression by 2...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a small activating RNA (Ribonucleic Acid) which consists of a sense oligonucleotide chain and an antisense oligonucleotide chain and is used for activating or up-regulating human p21 gene expression, and the sense oligonucleotide chain or the antisense oligonucleotide chain has more than 75% of homology with any continuous fragment with the length of 16-35 nucleotides in a target gene sequence of a human p21 gene promoter. Wherein the target sequence of the human p21 gene is selected from a group consisting of sequences as shown in SEQ ID NO: 5, 6, 7, 8, 9, 10, 11 and 12.

Description

technical field [0001] The invention relates to the field of molecular biology, in particular to the use of double-stranded small RNAs targeting gene promoter sequences to positively regulate gene expression. Background technique [0002] Double-stranded small nucleic acid molecules including chemically synthesized oligoribonucleotides such as small activating RNA (saRNA) and naturally occurring oligoribonucleotides such as microribonucleotides (miRNA) have been shown to target This phenomenon is called RNA activation (RNAa) (Li, Okino et al. (2006) Proc Natl Acad Sci U S A 103:17337-17342; Janowski, Younger et al. (2007) Nat Chem Biol 3:166-173; Place, Li et al. (2008) Proc Natl Acad Sci U S A105:1608-1613; Huang, Place et al. al. (2012) Nucleic Acids Res 40:1695-1707; Li (2017) Adv Exp Med Biol 983:1-20). Studies have shown that RNA activation is an endogenous molecular mechanism that is evolutionarily conserved from Caenorhabditis elegans to humans (Huang, Qin et al. (2...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/113C12N15/10A61K31/713A61P35/00
CPCC12N15/113A61P35/00C12N2310/113C12N2330/30A61K31/713C12N15/1135C12N2320/11C12N2310/321C12N2310/332A61K47/6911C12N15/102C12N15/87C12N2310/31C12N2310/33C12N2310/531
Inventor 李龙承姜武林吴建成
Owner SINO US INST OF RNA TECH